The two main types of cannabinoid receptors are CB1 and CB2. CB1 receptors sit largely on neurons in the brain and nervous system, where they mediate the psychoactive effects associated with THC. CB2 receptors sit largely on immune cells, where they influence inflammation and immune signaling. Beyond that classical pair, researchers also study several non-classical receptors that respond to cannabinoids, including GPR55, TRPV1, PPARs, and the serotonin receptor 5-HT1A.

Why receptors come in types at all

Receptors are proteins that sit on or inside cells and change what a cell does when a molecule binds to them. Cannabinoid receptors are part of the endocannabinoid system, a signaling network that helps regulate mood, appetite, pain perception, memory, immune response, and temperature. The body makes its own signaling molecules for this system, called endocannabinoids, the best known being anandamide and 2-AG. Plant compounds such as THC and CBD, and lab-made compounds, can interact with the same receptors, which is why the receptor map is the starting point for understanding effects.

The classical receptors: CB1 and CB2

CB1 and CB2 were the first cannabinoid receptors to be identified and cloned, and most cannabis pharmacology still centers on them. Both are G protein-coupled receptors, meaning they trigger signaling cascades inside the cell rather than opening a channel directly.

CB1 receptors

CB1 is abundant in the central nervous system, with dense populations in regions tied to memory, emotion, movement, and pain processing. THC acts as a partial agonist at CB1, which is the main reason it produces a high, shifts time perception, and stimulates appetite. Some lab research suggests CBD does not activate CB1 directly and may act as a negative allosteric modulator, meaning it can change how the receptor responds to other molecules without switching it on itself.

CB2 receptors

CB2 is found mainly on immune cells such as macrophages and lymphocytes, and it also appears in peripheral tissues and in some parts of the nervous system. Activation of CB2 is not associated with a high, which is why it draws interest in research on inflammation, pain, and immune regulation. The endocannabinoid 2-AG binds both receptors, and THC interacts with CB2 as well, though the CB1 interaction is the one most users notice.

Non-classical receptors that respond to cannabinoids

Several other receptors react to cannabinoids and endocannabinoids but are not classified as classical cannabinoid receptors:

  • GPR55 is an orphan receptor sometimes referred to as a third cannabinoid receptor. Some phytocannabinoids activate it, and it has been studied for roles in pain and bone signaling.
  • TRPV1 is the vanilloid receptor best known as the target of capsaicin from chili peppers. It responds to heat and to CBD, and it plays a role in pain and inflammation sensation.
  • PPAR alpha and PPAR gamma are nuclear receptors involved in metabolism, inflammation, and gene expression. Some endocannabinoids and phytocannabinoids act on them.
  • 5-HT1A is a serotonin receptor that CBD activates in studies, which is one proposed route for its effects on anxiety.
  • GPR119 appears in the gut and pancreas and is studied for metabolic signaling.

Why receptor types matter when you choose a product

A product label rarely tells you which receptors a molecule will touch. What a label does control is how the cannabinoids reach your body: an edible or beverage is absorbed through digestion, a vape or tincture reaches the bloodstream faster, and a topical acts on local tissue. Convenience shapes onset time, dose control, and duration, but it does not change which receptors a given molecule targets. THC will still meet CB1, and CBD will still interact with the receptor set described above, regardless of the format you pick.

Two practical points follow from the receptor map. First, THC-dominant products lean on CB1 activity, so effects like altered perception and appetite changes are expected. Second, CBD-dominant products are not simply weak THC; they act across a different mix of targets, which is why the two are often described as behaving like different tools rather than different strengths of the same tool.

Key takeaways

  • CB1 and CB2 are the two classical cannabinoid receptors.
  • CB1 is concentrated in the nervous system and is linked to THC's psychoactive effects.
  • CB2 is concentrated on immune cells and is studied for inflammation and immune signaling.
  • GPR55, TRPV1, PPARs, 5-HT1A, and GPR119 also respond to cannabinoids but sit outside the classical classification.
  • Delivery format changes timing and dose control, not receptor selectivity.